Nexalin Technology (NXL) Asset Writedowns and Impairment (2022 - 2024)
Nexalin Technology (NXL) posted quarterly Asset Writedowns and Impairment of $496.0 for Q1 2024, down 63.82% year-over-year from $1371.0 in Q2 2023, and down 68.08% quarter-over-quarter from $1554.0 in Q4 2023.
Nexalin Technology (NXL) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends
Nexalin Technology's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $496.0 for Q1 2024.
- In Q1 2024, Asset Writedowns and Impairment fell 63.82% year-over-year to $496.0; the TTM figure through Dec 2024 stood at $496.0 (down 91.39% YoY), while the FY2025 annual figure was $16380.0, up 3202.42% from the prior year.
- Asset Writedowns and Impairment for Q1 2024 stood at $496.0, down from $1554.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $8639.0 in Q3 2022, with the low at -$5987.0 in Q4 2022.
- The 3-year median for Asset Writedowns and Impairment is $1371.0 (2023), against an average of $1271.8.
- Peak annual rise in Asset Writedowns and Impairment reached 125.96% in 2023, while the deepest fall reached 83.4% in 2023.
- Nexalin Technology's Asset Writedowns and Impairment stood at -$5987.0 in 2022, then surged by 125.96% to $1554.0 in 2023, then slumped by 68.08% to $496.0 in 2024.
- Business Quant data shows NXL's Asset Writedowns and Impairment at $496.0 in Q1 2024, $1554.0 in Q4 2023, and $1434.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 7.08 Mn | 6.07 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 496.00 |
| Mar 31, 2024 | 496.00 |
| Dec 31, 2023 | 1,554.00 |
| Dec 31, 2023 | 1,554.00 |
| Sep 30, 2023 | 1,434.00 |
| Sep 30, 2023 | 1,434.00 |
| Jun 30, 2023 | 1,403.00 |
| Jun 30, 2023 | 1,403.00 |
| Mar 31, 2023 | 1,371.00 |
| Mar 31, 2023 | 1,371.00 |
| Dec 31, 2022 | -5,987.00 |
| Dec 31, 2022 | -5,987.00 |
| Sep 30, 2022 | 8,639.00 |
| Sep 30, 2022 | 8,639.00 |
| Jun 30, 2022 | 1,282.00 |
| Jun 30, 2022 | 1,282.00 |
| Mar 31, 2022 | 1,254.00 |
| Mar 31, 2022 | 1,254.00 |